Project Grant K99AI182422
Award Date
12/13/24
Completion Date
11/30/26
Dollars Obligated
$135K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
This federal Project Grant award, valued at $427,000.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to establish a continuous in vitro culture system for the propagation of the Babesia microti parasite in human red blood cells. The primary objective is to develop a robust platform to enable future experimental investigations, specifically the identification and characterization of...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $874,372 to Yale University to conduct research on parasite-derived vesicles in Babesia virulence and vaccine development. The research aims to elucidate the molecular mechanisms by which Babesia species communicate with their host and leverage this knowledge to engineer an effective and safe vaccine for...
This Project Grant award of $431,143 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to develop methods for continuous in vitro propagation of the Babesia microti parasite. The key objectives are to: (1) propagate B. microti within tick cell lines, (2) test the capacity for B. microti to replicate using erythrocyte lysate substrates, and (3) utilize a phylogenetic metabolomics...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $924,000.00 in funding to Tufts University School of Medicine to support research aimed at mitigating the adhesion of Plasmodium falciparum-infected red blood cells to the vascular endothelium, which is a key contributor to the severe complications of cerebral malaria. The research project, running from July...
This $147,656 federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the role of transmembrane proteins in the cell division process of the malaria parasite Plasmodium falciparum. The award, effective January 22, 2025 through October 31, 2027, will enable the integration of biochemical and super-resolution microscopy approaches to decipher...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $250,573 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Pittsburgh to investigate how host genetic variations impact the transmission and progression of Babesia microti infection, the primary cause of human babesiosis, a tick-borne infectious disease. The two-year project aims to leverage the Collaborative Cross mouse model to map quantitative trait loci (QTLs) associated with...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $700,288.00 in funding to the University of South Florida to conduct research on identifying genetic factors associated with the sexual stage development of the malaria parasite Plasmodium falciparum. The project leverages a functional genomics approach using random PiggyBac mutagenesis to screen for genes...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) in the amount of $215,751 to the Regents of the University of California at Riverside. The grant will fund research to identify and characterize RNA-binding proteins (RBPs) and RNA-dependent proteins (RDPs) in the malaria parasite Plasmodium falciparum, with a focus on the parasite's sexual differentiation stage. The research aims to...
This $805,375 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research program will fund a multi-principal investigator (MPI) research project to elucidate the cellular tropism, receptor usage, and pathogenesis mechanisms of Pararubulaviruses (PruBVs) - an emerging group of bat-derived paramyxoviruses. The primary goal is to fill critical knowledge gaps about these viruses, which can cause severe disease...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to investigate heme homeostasis mechanisms in the malaria parasite Plasmodium falciparum. The $153,056 award will fund a 1.5-year research project at The Washington University to identify and characterize heme-binding proteins that enable the parasite to maintain appropriate heme levels during blood stage replication....